Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 15, 2023 11:18 ET | Source: Research and Markets

Ostomy Care and Accessories Market Size, Share & Trends Analysis Report 2023-2030, Featuring Profiles of Coloplast, Hollister, B. Braun, Convatec, Welland Medical and Salts Healthcare

Dublin, Nov. 15, 2023 (GLOBE NEWSWIRE) -- The "Ostomy Care And Accessories Market Size, Share & Trends Analysis Report By Product (Bags, Accessories), By Application (Colostomy, Ileostomy,...
November 14, 2023 04:30 ET | Source: Transparency Market Research

Bowel Management Systems Market is Predicted to Reach USD 3 billion at a CAGR of 4% by 2031 | Report by Transparency Market Research Inc.

Wilmington, Delaware, United States, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. -The global bowel management systems market was estimated at a value of US$ 2.03 billion in...
November 08, 2023 09:01 ET | Source: Janssen Pharmaceutica NV

New Real-World Data Show TREMFYA® (guselkumab) Was Associated With Clinically Meaningful Improvements in Patient-Reported Outcomes for Adults Living With Active Psoriatic Arthritis

Beerse, Belgium , Nov. 08, 2023 (GLOBE NEWSWIRE) -- FOR EUROPEAN AND UK MEDICAL AND TRADE MEDIA ONLY BEERSE, BELGIUM, 8 November 2023 – Janssen Pharmaceuticals, Inc., a Johnson &...
November 02, 2023 09:50 ET | Source: SPHERICAL INSIGHTS LLP

Global Stoma Care Market Size to Exceed USD 6.4 Billion by 2032 | CAGR 6.8%

New York, United States , Nov. 02, 2023 (GLOBE NEWSWIRE) -- The Global Stoma Care Market Size is to Grow from USD 3.3 Billion in 2022 to 6.4 Billion by 2032, at a Compound Annual Growth Rate (CAGR)...
October 30, 2023 10:28 ET | Source: Emergen Research

Global Medical Endoscope Devices Market Size to Reach USD 58.25 Billion in 2032 | Emergen Research

Vancouver, Oct. 30, 2023 (GLOBE NEWSWIRE) -- The global medical endoscope devices market size was USD 29.1 Billion in 2022 and is expected to register a rapid revenue CAGR of 7.1% during the...
October 30, 2023 07:14 ET | Source: Fortune Business Insights

Inflammatory Bowel Disease Treatment Market to hit USD 39.19 Billion by 2030 | Fortune Business Insights

Pune, India, Oct. 30, 2023 (GLOBE NEWSWIRE) -- The inflammatory bowel disease treatment market revenue is set to rise from USD 26.55 billion in 2023 to USD 39.19 billion by 2030 at a CAGR of 5.7%...
October 30, 2023 03:30 ET | Source: Transparency Market Research

Insufflation Devices Market to Exceed USD 4.7 billion by 2032 Rise at 6.7% CAGR Exclusive Report by Transparency Market Research

Wilmington, Delaware, United States, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - Insufflation devices market are expected to reach a market valuation of US$ 4.7 billion by...
October 24, 2023 13:00 ET | Source: DelveInsight Business Research LLP

Ulcerative Colitis Market to Grow Positively by 2032, Predicts DelveInsight | Key Companies - Arena, Pfizer, Abivax, InDex, AbbVie, Boehringer Ingelheim, Janssen Pharmaceuticals, Landos Biopharma, NImmune, Merck, Mesoblast

New York, USA, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Ulcerative Colitis Market to Grow Positively by 2032, Predicts DelveInsight | Key Companies - Arena, Pfizer, Abivax, InDex, AbbVie, Boehringer...
October 23, 2023 01:00 ET | Source: F. Hoffmann-La Roche Ltd

[Ad hoc announcement pursuant to Art. 53 LR] Roche enters into a definitive agreement to acquire Telavant including rights to novel TL1A directed antibody (RVT-3101) for the treatment of inflammatory bowel disease from Roivant

Roche will gain the rights to develop, manufacture and commercialise RVT-3101 in the US and Japan for the treatment of inflammatory bowel disease and potentially multiple other diseasesRVT-3101 is a...
October 23, 2023 01:00 ET | Source: Roivant Sciences

Roche Enters Into a Definitive Agreement to Acquire Telavant Including Rights to Novel TL1A Directed Antibody (RVT-3101) for the Treatment of Inflammatory Bowel Disease From Roivant

Roche will gain the rights to develop, manufacture and commercialize RVT-3101 in the US and Japan for the treatment of inflammatory bowel disease and potentially multiple other diseasesRVT-3101 is a...